Horizon Kinetics Asset Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.44M | Sell |
37,392
-1,273
| -3% | -$48.9K | 0.02% | 150 |
|
2025
Q1 | $1.5M | Sell |
38,665
-1,200
| -3% | -$46.5K | 0.02% | 139 |
|
2024
Q4 | $1.35M | Buy |
39,865
+1,673
| +4% | +$56.6K | 0.02% | 151 |
|
2024
Q3 | $1.56M | Buy |
38,192
+13,027
| +52% | +$533K | 0.02% | 139 |
|
2024
Q2 | $969K | Hold |
25,165
| – | – | 0.02% | 164 |
|
2024
Q1 | $1.08M | Hold |
25,165
| – | – | 0.02% | 154 |
|
2023
Q4 | $933K | Buy |
25,165
+227
| +0.9% | +$8.41K | 0.02% | 159 |
|
2023
Q3 | $904K | Buy |
24,938
+1,100
| +5% | +$39.9K | 0.02% | 164 |
|
2023
Q2 | $850K | Buy |
23,838
+1,000
| +4% | +$35.6K | 0.02% | 170 |
|
2023
Q1 | $813K | Buy |
22,838
+9,560
| +72% | +$340K | 0.02% | 172 |
|
2022
Q4 | $467K | Hold |
13,278
| – | – | 0.01% | 216 |
|
2022
Q3 | $391K | Buy |
13,278
+361
| +3% | +$10.6K | 0.01% | 234 |
|
2022
Q2 | $703K | Hold |
12,917
| – | – | 0.01% | 185 |
|
2022
Q1 | $703K | Sell |
12,917
-43
| -0.3% | -$2.34K | 0.01% | 205 |
|
2021
Q4 | $714K | Sell |
12,960
-400
| -3% | -$22K | 0.02% | 208 |
|
2021
Q3 | $638K | Hold |
13,360
| – | – | 0.01% | 217 |
|
2021
Q2 | $665K | Sell |
13,360
-5,440
| -29% | -$271K | 0.01% | 212 |
|
2021
Q1 | $839K | Buy |
18,800
+80
| +0.4% | +$3.57K | 0.02% | 192 |
|
2020
Q4 | $861K | Buy |
18,720
+160
| +0.9% | +$7.36K | 0.03% | 186 |
|
2020
Q3 | $873K | Hold |
18,560
| – | – | 0.04% | 181 |
|
2020
Q2 | $946K | Buy |
18,560
+243
| +1% | +$12.4K | 0.03% | 168 |
|
2020
Q1 | $868K | Sell |
18,317
-560
| -3% | -$26.5K | 0.04% | 155 |
|
2019
Q4 | $1.11M | Hold |
18,877
| – | – | 0.03% | 156 |
|
2019
Q3 | $1.01M | Sell |
18,877
-800
| -4% | -$42.7K | 0.03% | 162 |
|
2019
Q2 | $984K | Buy |
19,677
+139
| +0.7% | +$6.95K | 0.03% | 172 |
|
2019
Q1 | $1.02M | Buy |
+19,538
| New | +$1.02M | 0.03% | 166 |
|